-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RGm1GAS8YI5RA29HYFCf89IGdLWCBVtdSBJP1sCXSB2BnI/90HKV3ztHLeDRWfTQ SLtclMCBa0Ctua1mjZNP/Q== 0001144204-05-033458.txt : 20051101 0001144204-05-033458.hdr.sgml : 20051101 20051101143513 ACCESSION NUMBER: 0001144204-05-033458 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051031 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20051101 DATE AS OF CHANGE: 20051101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARGAN INC CENTRAL INDEX KEY: 0000100591 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 131947195 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31756 FILM NUMBER: 051169370 BUSINESS ADDRESS: STREET 1: ONE CHURCH STREET STREET 2: SUITE 302 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301 315-0027 MAIL ADDRESS: STREET 1: ONE CHURCH STREET STREET 2: SUITE 302 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: PUROFLOW INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ULTRA DYNAMICS CORP DATE OF NAME CHANGE: 19830522 8-K 1 v028103_8-k.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 31, 2005 ARGAN, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31756 13-1947195 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) One Church Street, Suite 302, Rockville, MD 20850 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (301) 315-0027 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events. On October 31, 2005, Argan, Inc. issued a press release announcing that the Naples, Florida manufacturing facilities of its Vitarich Laboratories, Inc. subsidiary are fully operational after losing six days of production due to lack of power and water utilities in the aftermath of Hurricane Wilma. The unavailability of power and water utilities caused a decrease in the customer shipments made at the end of the fiscal third quarter, and the decrease of shipments will likely have a negative impact on the operating performance of Vitarich in the fiscal third quarter. A copy of the Argan, Inc. press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description ----------- ----------- 99.1 Argan, Inc. Press Release issued October 31, 2005. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 1, 2005 ARGAN, INC. By: /s/ Rainer Bosselmann --------------------------------- Rainer Bosselmann Chairman of the Board and Chief Executive Officer EXHIBIT INDEX Exhibit No. Description ----------- ----------- 99.1 Argan, Inc. Press Release issued October 31, 2005. EX-99.1 2 v028103_ex99-1.txt Exhibit 99.1 [LOGO OF ARGAN, INC.] NEWS - FOR IMMEDIATE RELEASE Date: October 31, 2005 From: Argan, Inc. Contact: Haywood Miller Fax: 301-315-0064 Phone: 301-315-0027 ARGAN ANNOUNCES THAT VITARICH MANUFACTURING FACILITIES ARE FULLY OPERATIONAL AFTER LOSING SIX DAYS OF PRODUCTION DUE TO LACK OF POWER IN THE AFTERMATH OF HURRICANE WILMA Rockville, MD - Argan, Inc. (OTC; BSE: AGAX.PK; AGX) announces that the Naples, FL manufacturing facilities of its Vitarich Laboratories, Inc. subsidiary are fully operational after losing six days of production due to lack of power and water utilities in the aftermath of Hurricane Wilma. Despite the plant sustaining minimal damage in the storm, the unavailability of power and water utilities over the past week caused a decrease in the customer shipments made at the end of the fiscal third quarter. The decrease of shipments will likely have a negative impact on the operating performance of Vitarich in the fiscal third quarter. "The staff at Vitarich performed remarkably well given the difficult circumstances of this storm. Unfortunately, the availability of water and power was outside our control. The timing of the storm to coincide with the end of our fiscal third quarter will have a negative impact on operations for the quarter, but should have a negligible impact on our performance for the year." stated Rainer Bosselmann. Argan is a publicly traded holding company, focusing on companies that provide products and services to growth industries. Vitarich Laboratories, a wholly owned subsidiary of Argan located in Naples, FL, is a farm-to-market, vertically integrated contract private label manufacturer of premium nutraceutical products, including nutritional and whole-food dietary supplements and other personal healthcare products. Argan has another wholly owned subsidiary, Southern Maryland Cable, Inc., that provides inside premise wiring services to the federal government and also provides underground and aerial construction services and splicing to major telecommunications and utilities customers. For more information on Argan, go to www.arganinc.com and to www.vitarichlabs.com for more information on Vitarich Laboratories. This press release contains certain-forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange act of 1934, as amended. Although Argan believes the assumptions underlying the forward-looking statements contained herein, including the development plans of Argan, are reasonable, any of the assumptions could be inaccurate and therefore, there can be no assurance that the forward-looking statements contained in the press release will prove to be accurate. In light of significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Argan or any other person that the objectives and plans of Argan will be achieved. -----END PRIVACY-ENHANCED MESSAGE-----